Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondrial Myopathies | 1 | 2023 | 28 | 0.210 |
Why?
|
| Colitis, Ulcerative | 1 | 2022 | 208 | 0.170 |
Why?
|
| Crohn Disease | 1 | 2022 | 283 | 0.160 |
Why?
|
| Enterobacteriaceae | 1 | 2018 | 35 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 314 | 0.150 |
Why?
|
| Colistin | 1 | 2018 | 30 | 0.150 |
Why?
|
| Carrier State | 1 | 2018 | 77 | 0.140 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 134 | 0.130 |
Why?
|
| Quality of Life | 1 | 2023 | 1943 | 0.110 |
Why?
|
| Hospitalization | 1 | 2020 | 1755 | 0.100 |
Why?
|
| Streptolysins | 2 | 2001 | 9 | 0.090 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2001 | 82 | 0.080 |
Why?
|
| Pneumococcal Infections | 2 | 2001 | 274 | 0.070 |
Why?
|
| Bacteremia | 2 | 2001 | 407 | 0.070 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2023 | 10 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 193 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2023 | 273 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2001 | 65 | 0.050 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 772 | 0.050 |
Why?
|
| Streptococcus pneumoniae | 2 | 2001 | 372 | 0.040 |
Why?
|
| Smokers | 1 | 2020 | 39 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 281 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 75 | 0.040 |
Why?
|
| United Kingdom | 1 | 2020 | 192 | 0.040 |
Why?
|
| Conjunctivitis, Bacterial | 1 | 1999 | 5 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 294 | 0.040 |
Why?
|
| Bacterial Proteins | 3 | 2018 | 886 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1617 | 0.040 |
Why?
|
| Metabolomics | 1 | 2022 | 419 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 386 | 0.040 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2018 | 55 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 398 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 461 | 0.040 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 73 | 0.040 |
Why?
|
| China | 1 | 2018 | 245 | 0.040 |
Why?
|
| Cephalosporins | 1 | 2018 | 138 | 0.030 |
Why?
|
| Plasmids | 1 | 2018 | 514 | 0.030 |
Why?
|
| Middle Aged | 5 | 2023 | 26452 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2018 | 280 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2023 | 12292 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 505 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2018 | 305 | 0.030 |
Why?
|
| Humans | 9 | 2023 | 124307 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1414 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 786 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1308 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 717 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 597 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 6071 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 6469 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2018 | 989 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 2429 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 2416 | 0.020 |
Why?
|
| Male | 4 | 2023 | 60967 | 0.020 |
Why?
|
| Female | 4 | 2023 | 66235 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19481 | 0.020 |
Why?
|
| Child | 2 | 2022 | 24435 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2001 | 105 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2001 | 67 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2001 | 202 | 0.010 |
Why?
|
| Virulence | 1 | 2001 | 262 | 0.010 |
Why?
|
| Serotyping | 1 | 1999 | 178 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1999 | 107 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 154 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 816 | 0.010 |
Why?
|
| Eye | 1 | 1999 | 227 | 0.010 |
Why?
|
| Phylogeny | 1 | 1999 | 696 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 1584 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 2031 | 0.010 |
Why?
|
| Adult | 3 | 2001 | 29385 | 0.010 |
Why?
|
| Prognosis | 1 | 2000 | 4549 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 6272 | 0.010 |
Why?
|
| Risk Factors | 1 | 2000 | 10141 | 0.000 |
Why?
|
| Infant | 1 | 1999 | 12473 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1999 | 14042 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 17729 | 0.000 |
Why?
|
| Animals | 1 | 2001 | 34149 | 0.000 |
Why?
|